Raymond James Financial Services Advisors, Inc. Verastem, Inc. Transaction History

Raymond James Financial Services Advisors, Inc.

$73.5 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 08, 2023	SELL	$0.33 - $10.44 $330 - $10,440	-1,000 Reduced 7.86%	11,729 $4,000
Q2 2022 Aug 12, 2022	SELL	$1.02 - $1.83 $6,258 - $11,228	-6,136 Reduced 32.53%	12,729 $15,000
Q1 2022 May 11, 2022	BUY	$1.06 - $2.1 $1,014 - $2,009	957 Added 5.34%	18,865 $27,000
Q4 2021 Feb 08, 2022	SELL	$2.05 - $3.2 $996 - $1,555	-486 Reduced 2.64%	17,908 $37,000
Q3 2021 Nov 02, 2021	SELL	$2.54 - $4.07 $614 - $984	-242 Reduced 1.3%	18,394 $57,000
Q2 2021 Aug 11, 2021	BUY	$2.57 - $4.85 $6,162 - $11,630	2,398 Added 14.77%	18,636 $76,000
Q1 2021 May 14, 2021	SELL	$1.9 - $2.82 $471 - $699	-248 Reduced 1.5%	16,238 $40,000
Q4 2020 Feb 12, 2021	BUY	$1.15 - $2.4 $919 - $1,920	800 Added 5.1%	16,486 $35,000
Q3 2020 Nov 04, 2020	SELL	$1.11 - $1.68 $11,100 - $16,800	-10,000 Reduced 38.93%	15,686 $19,000
Q2 2020 Jul 17, 2020	SELL	$1.69 - $4.2 $14,745 - $36,645	-8,725 Reduced 25.36%	25,686 $44,000
Q1 2020 Apr 21, 2020	SELL	$1.26 - $3.38 $3,452 - $9,261	-2,740 Reduced 7.38%	34,411 $91,000
Q4 2019 Feb 12, 2020	BUY	$0.86 - $1.44 $4,300 - $7,200	5,000 Added 15.55%	37,151 $50,000
Q3 2019 Nov 07, 2019	SELL	$1.21 - $1.59 $13,310 - $17,490	-11,000 Reduced 25.49%	32,151 $39,000
Q2 2019 Aug 06, 2019	BUY	$1.25 - $3.14 $6,925 - $17,395	5,540 Added 14.73%	43,151 $65,000
Q1 2019 May 06, 2019	BUY	$2.79 - $4.09 $29,244 - $42,871	10,482 Added 38.64%	37,611 $111,000
Q4 2018 Feb 11, 2019	BUY	$3.23 - $7.01 $5,038 - $10,935	1,560 Added 6.1%	27,129 $91,000
Q3 2018 Nov 14, 2018	BUY	$6.86 - $9.97 $37,730 - $54,835	5,500 Added 27.41%	25,569 $185,000
Q2 2018 Jul 30, 2018	BUY	$2.88 - $8.67 $3,916 - $11,791	1,360 Added 7.27%	20,069 $138,000
Q1 2018 Apr 16, 2018	BUY	$2.92 - $3.81 $2,876 - $3,752	985 Added 5.56%	18,709 $56,000
Q4 2017 Feb 09, 2018	SELL	$2.99 - $4.85 $316 - $514	-106 Reduced 0.59%	17,724 $54,000
Q3 2017 Oct 26, 2017	BUY	$3.01 - $5.41 $17,638 - $31,702	5,860 Added 48.96%	17,830 $84,000
Q2 2017 Aug 15, 2017	BUY	N/A	11,970	11,970 $26,000

Others Institutions Holding VSTM

# of Institutions

Shares Held

297K

Call Options Held

Put Options Held

Telemetry Investments, L.L.C. New York, NY

225K
Shares

$1.16 Million
0.14% of portfolio
Beaumont Financial Partners, LLC

48K
Shares

$248,160
0.0% of portfolio
Eaton Vance Management Boston, MA

20K
Shares

$103,400
0.0% of portfolio
American Portfolios Advisors Holbrook, NY

2.99K
Shares

$15,432
0.0% of portfolio
Brewin Dolphin Wealth Management LTD Conskleagh, Dublin, L2

1.07K
Shares

$5,552
0.0% of portfolio

View Full List

About Verastem, Inc.

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $1.09B
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

More about VSTM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.

Account